Joanna P. Wolkowski joanna.wolkowski.wg11@wharton.upenn.edu


Middlebury College, Middlebury, VT B.A., cum Laude, Chemistry, 1999 Yale University, New Haven, CT M.S., Chemistry, 2001


Kyutae Yoo, Ph.D. kyutae.yoo.wg11@wharton.upenn.edu


Cornell University, Ithaca, NY B.S., Electrical Engineering, 1997 Ph.D., Electrical Engineering, 2002


Derek H. Yuan


derek.yuan.wg11@wharton.upenn.edu Duke University, Durham, NC


B.S.E., Biomedical and Electrical Engineering, 2005


Georgetown University School of Medicine, Washington, DC M.D. Candidate, 2011


An opportunity in pharmaceutical strategy.


The Boston Consulting Group, Summit, NJ


Summer Consultant, Summer 2010 Developed and operationalized asset strategy for global biopharmaceutical company through in-depth market testing, quantitative research, and rig- orous analytics to determine optimal resourcing and implementation for portfolio enhancement.


Pfizer, Inc., New London, CT Strategic Management Group, Summer Consultant, Summer 2009 Led Safety & Risk Management project team through complex analysis and innovative design of Pfizer-Wyeth integration strategy.


Sierra Nevada Brewing Company, Berkeley, CA


Sales Representative, 2008-2009 Grew distribution network by identifying new sales channels, building customer relationships, and demonstrating value proposition and return on investment.


Pfizer, Inc., Groton, CT Pfizer Global Pharmaceuticals, Healthcare Representative, 2006-2008 Increased territory sales ranking from bottom 2% to top 4% within eight months by analyzing sales drivers, managing over 250 customer relation- ships, and strategically targeting growth opportunities.


Pfizer Global R&D,


Senior Associate Scientist, 2002-2006 Contributed to identification, synthe- sis, and characterization of a clinical drug candidate through synthesis of analogs, analysis of SAR, and design of novel target molecules.


30


An opportunity in product management or strategic planning in the medical device industry.


Boston Scientific, Valencia, CA MBA Marketing Intern, Summer 2010 Assessed the cost of post-implant service for patients with spinal cord stimulators. Created remote patient programming service model designed to lower the cost by 30%. Provided business case of new service model with reimbursement strategy and regulatory assessment to senior executives.


Samsung Electronics, Ki-heung, Korea Product Manager, Bio & Health Group, 2006-2009


Managed crossfunctional team through all phases of product devel- opment of Telemedicine solution from concept phase to commercial scale-up phase within 18 months. Coordinated Samsung-Kaiser Permanente pilot for Diabetes management. Developed “Samsung Telemedicine Solution” business plan, adopted by a subsidiary of Samsung Electronics.


Task Force Leader, 2005-2006 Led task force to develop Samsung’s market entry strategy to home-health care domain. Spearheaded contract negotiations with Kaiser Permanente for joint development of Telemedicine Solution, resulting in approval of multi-million dollar Samsung Telemedicine project.


Project Leader, 2002-2005 Led development of electronic molecular diagnostic platform for point-of-care use, resulting in 23 patents filed, and innovative technology award at 2004 Samsung Technology Fair.


An opportunity to leverage my medical and business backgrounds to pursue a career in health care investment banking.


Leerink Swann, New York, NY Summer Associate, Investment Banking, Summer 2010


Performed due diligence and deep dive research on the health care industry for engaged transactions. Drafted internal and external presen- tation materials, including: internal committee memorandums, manage- ment presentations, and pitch books. Conducted valuations of companies in the health care industry using different methodologies including discounted cash flow, comparable public company trading multiples, and precedent transaction multiples.


Leerink Swann, Boston, MA Summer Associate, Strategic Advisors, Summer 2008


Partnered with the CEO to expand the capabilities of MEDACorp to the $5B Pharmaceutical Benefit Manager market. Evaluated potential new markets for expanding VIDAZA®’s existing global revenues of $117M. Designed project workstreams for major pharmaceutical and biotech - nology companies, concerning issues such as market research, restructuring strategy and business plan develop- ment. Led the drafting and creation of several client presentations.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40